Information

Information
CTO Nakayama Contributes Invited Article to Experimental Medicine, Japan’s Leading Life Science Journal, on AI-Driven Drug DiscoveryNew!!
2026/3/12

GEXVal Inc.March 12, 2026 CTO Nakayama Contributes Invited Article to Experimental Medicine Special Issue on A […]

Read more
Information
GEXVal Selected as Presenting Company at Biotech Showcase™ 2026
2026/1/7

GEXVal Inc.January 7, 2026 GEXVal Selected as Presenting Company at Biotech Showcase™ 2026 GEXVal Inc. (Presid […]

Read more
Information
GEXVal Featured in BioCentury Article
2025/12/22

GEXVal Inc.December 22, 2025 GEXVal Featured in BioCentury Article “Raising the Sun: Japan Biotech Looks to Le […]

Read more
Information
GEXVal Senior Director Speaks at University of Tokyo Hospital Drug Discovery Training Program
2025/12/12

GEXVal Inc.December 12, 2025 GEXVal Senior Director Delivers Lecture at University of Tokyo Hospital TR/Academ […]

Read more
Information
GEXVal CEO Speaks at University of Tokyo Hospital Drug Discovery Training Program
2025/11/21

GEXVal Inc.November 21, 2025 GEXVal CEO Delivers a Lecture at University of Tokyo Hospital TR/Academia Drug Di […]

Read more